Skip to content

GLP-1 price check, Sep 28, 2026

We re-read 3,152 official sentences on 837 pages. 3,147 were still there, word for word. 5 were on pages that would not load. 89 come from official Word, Excel or PDF files, which this check does not download; they keep the date they were last read.

What changed

  • Page did not load: Covered drugs with prior authorization: Benzphetamine Contrave Diethylpropion or diethylpropion ER Lomaira Orlistat Phendimetrazine or phendimetrazine ER Phentermine capsules (Apidex-P and generics): 15mg, 30mg, 37.5mg Phentermine tablets (Apidex-P and generics): 37.5mg Saxenda Wegovy Xenical Zepbound mn.gov Used for: Medicaid MN: obesityCovered
  • Page did not load: Greater than or equal to 30 kg/m2 with no risk factors (for patient at least 18 years of age) OR Greater than or equal to 27 kg/m2 with at least one weight-related comorbid condition (e.g. hypertension, type 2 diabetes mellitus, or dyslipidemia) (for patient at least 18 years of age) mn.gov Used for: Medicaid MN: criteria
  • Page did not load: Patient, at least 18 years of age, must have at least 5% weight loss during the initial approval period mn.gov Used for: Medicaid MN: criteria
  • Page did not load: 6 months for Saxenda, Wegovy, Contrave, Xenical or orlistat; and may be renewed if renewal criteria is met. mn.gov Used for: Medicaid MN: criteria
  • Page did not load: I-961 TO REDUCE THE RISK OF SUSTAINED ESTIMATED GLOMERULAR FILTRATION RATE (EGFR) DECLINE, END-STAGE KIDNEY DISEASE, AND CARDIOVASCULAR DEATH accessdata.fda.gov Used for: Article: is-there-a-generic-ozempic

A sentence that is not found keeps its old date; after 7 days the price is marked as not re-checked until a person reads the page again. Fixes are logged on the corrections page.

In files we did not re-read

Every page we opened

Official pageSentences still there
accessdata.fda.gov/scripts/cder/ob/results_exclusivity.cfm0 of 1
mn.gov/dhs/partners-and-providers/policies-procedures/minnesota-health-care-programs/provider/types/rx/pa-criteria/anti-obesity-medications.jsp0 of 4
aad.org/public/everyday-care/skin-care-secrets/prevent-skin-problems/glp1-drugs-and-side-effects3 of 3
aafprs.org/Media/Press_Releases/The_Ozempic_Face.aspx2 of 2
aarpmedicareplans.com/shop/prescription-drug-plans.html1 of 1
aboutamazon.com/news/retail/amazon-glp1-management-program12 of 12
aboutamazon.com/news/retail/amazon-pharmacy-glp-1-medicare2 of 2
accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=0217732 of 2
accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=0223411 of 1
accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=2063211 of 1
accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=2096372 of 2
accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=2130511 of 1
accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=2152563 of 3
accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=2158663 of 3
accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=2178063 of 3
accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=2183162 of 2
accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=2203142 of 2
accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=2209342 of 2
accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=209637&Appl_type=N5 of 5
accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=215256&Appl_type=N3 of 3
accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=218316&Appl_type=N1 of 1
accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Liraglutide%20Injection&st=d1 of 1
admincode.legislature.state.al.us/api/graphql?operationName=publicCode&variables=%7B%22number%22%3A%22560-X-16-.01%22%7D&extensions=%7B%22persistedQuery%22%3A%7B%22version%22%3A1%2C%22sha256Hash%22%3A%22a7128a1df313f43c76196950e7339e8d12d27420%22%7D%7D2 of 2
aetna.com/cpb/medical/data/1_99/0039.html1 of 1
aetna.com/employers-organizations/glp1-benefits-coverage.html1 of 1
aetna.com/faqs-health-insurance/pharmacy-faqs.html4 of 4
aetna.com/medicare/understanding-medicare/does-medicare-cover-ozempic.html2 of 2
aetna.com/medicare/understanding-medicare/medicare-glp-1-weight-loss-drug-coverage.html5 of 5
aetna.com/products/rxnonmedicare/data/2026/Antidiabetic_GLP-1,_GIP-GLP-1_Agonist_PA_with_Limit_2439-C_P05-2025_v4.html2 of 2
aetna.com/products/rxnonmedicare/data/2026/Weight_Loss_(BMI%2035)_GIP-GLP-1,_GLP-1_Agonists_PA_with_Limit_6450-C_P08-2025_v8.html18 of 18
ahca.myflorida.com/medicaid/medicaid-policy-quality-and-operations/medicaid-policy-and-quality/medicaid-policy/pharmacy-policy/prescribed-drug-services.html1 of 1
ahca.myflorida.com/medicaid/prescribed-drugs/drug-criteria.html1 of 1
akleg.gov/basis/aac.asp?media=print&secStart=7.120.112&secEnd=7.120.1121 of 1
ambetterhealth.com/en/ar/provider-resources/provider-news/glucagon-like-peptide-1-agonists-for-weight-loss/1 of 1
ambetterhealth.com/en/ar/resources/member-news/glp-1-medications-coverage-exclusions-for-weight-loss-treatment/2 of 2
ambetterhealth.com/en/tx/provider-resources/provider-news/effective-march-first-2026-pharmacy-and-biopharmacy-policy-updates/6 of 6
ambetterhealth.com/en/tx/provider-resources/provider-news/pharmacy-and-biopharmacy-policies-effective-june-2026/4 of 4
ambetterhealth.com/en/tx/resources/pharmacy-resources/3 of 3
amgen.com/newsroom/press-releases/2025/06/results-from-amgens-phase-2-obesity-study-of-monthly-maritide-presented-at-the-american-diabetes-association-85th-scientific-sessions2 of 2
amgen.com/newsroom/press-releases/2026/08/amgen-reports-second-quarter-2026-financial-results2 of 2
anthem.com/ca/ms/pharmacyinformation/priorauth.html2 of 2
anthem.com/pharmacy-information/drug-list-formulary1 of 1
anthem.com/pharmacy-information/for-members1 of 1
app.leg.wa.gov/wac/default.aspx?cite=182-530-21003 of 3
apps.legislature.ky.gov/law/kar/titles/907/023/010/3 of 3
apps.legislature.ky.gov/law/kar/titles/907/023/010/16437/2 of 2
apps.legislature.ky.gov/law/kar/titles/907/023/010/REG/1 of 1
apps.legislature.ky.gov/law/statutes/chapter.aspx?id=370841 of 1
apps.legislature.ky.gov/record/26rs/hb2.html2 of 2
apps.legislature.ky.gov/record/26rs/sb65.html2 of 2
arkleg.state.ar.us/Bills/Detail?id=HB1332&ddBienniumSession=2025%2F2025R1 of 1
arkleg.state.ar.us/Bills/Detail?id=HB1424&ddBienniumSession=2025%2F2025R2 of 2
aspe.hhs.gov/reports/comparing-prescription-drugs2 of 2
aspe.hhs.gov/topics/poverty-economic-mobility/poverty-guidelines1 of 1
azahcccs.gov/1 of 1
azleg.gov/legtext/57leg/2R/summary/S.1621HHS.DOCX.htm2 of 2
bcbsil.com/help-center2 of 2
bcbsil.com/prescription-drugs/managing-prescriptions/drug-lists1 of 1
bcbsil.com/producer/news/05-20-26-new-glp1-coverage-20269 of 9
bcbsil.com/provider/education/education-reference/news/2024/08-12-2024-30-day-supply-limit2 of 2
bcbsil.com/provider/education/education-reference/news/2025/5-20-2025-new-home-delivery-pharmacy-service-to-fill4 of 4
blueshieldca.com/en/bsp/medi-cal-members/pharmacy/medi-cal-rx-benefits1 of 1
blueshieldca.com/en/home/resources/pharmacy/drug-prior-authorizations1 of 1
blueshieldca.com/en/medicare/pharmacy-resources/medicare-formularies2 of 2
blueshieldca.com/en/provider/authorizations/policy-pharmacy/pharmacy-benefits1 of 1
blueshieldca.com/en/provider/news-education/news12 of 12
bms.wv.gov/prior-authorization-criteria2 of 2
budget.lis.virginia.gov/amendment/2026/1/HB30/Introduced/FA/291/9h/2 of 2
business.optum.com/en/pharmacy-benefit-management/affordability/weight-management.html2 of 2
capitol.texas.gov/BillLookup/History.aspx?LegSess=89R&Bill=HB26772 of 2
capitol.texas.gov/tlodocs/89R/fiscalnotes/html/HB02677H.htm1 of 1
carefirst.com/fedhmo/faqs/faqs-noom-med.html4 of 4
carefirst.com/fedhmo/plan-information/noom-med-enhanced-weight-management-support.html3 of 3
carefirst.com/medicare-options/compare-medicare-plans/pharmacy-faqs.html1 of 1
carelonrx.com/perspectives/glp1s-and-weight-loss-1012 of 2
carelonrx.com/perspectives/weight-management-program-updates3 of 3
cga.ct.gov/2026/sup/chap_319v.htm5 of 5
cga.ct.gov/current/pub/chap_319v.htm1 of 1
chfs.ky.gov/agencies/dms/dpo/ppb/Pages/default.aspx1 of 1
cigna.com/individuals-families/member-guide/offered-by-employers-drug-list1 of 1
cigna.com/individuals-families/member-guide/prescription-drug-lists2 of 2
clinicaltrials.gov/api/oas/v24 of 4
clinicaltrials.gov/api/v2/studies/NCT055677961 of 1
clinicaltrials.gov/api/v2/studies/NCT059290661 of 1
clinicaltrials.gov/api/v2/studies/NCT060665153 of 3
clinicaltrials.gov/api/v2/studies/NCT068588391 of 1
clinicaltrials.gov/api/v2/studies/NCT076684141 of 1
cloud.info.blueshieldca.com/xlob_bkr_news_December20247 of 7
cms.gov/marketplace/resources/data/essential-health-benefits2 of 2
cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge5 of 5
cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-part-d-plans4 of 4
cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-pharmacies4 of 4
cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-providers18 of 18
cms.gov/newsroom/fact-sheets/contract-year-2026-policy-and-technical-changes-medicare-advantage-program-medicare-prescription1 of 1
cms.gov/newsroom/fact-sheets/contract-year-2026-policy-and-technical-changes-medicare-advantage-program-medicare-prescription-final1 of 1
cms.gov/newsroom/press-releases/cms-launches-medicare-glp-1-bridge-expanding-access-glp-1-medications3 of 3
cms.gov/newsroom/press-releases/coming-soon-cms-provide-50-monthly-access-glp-1-medications-medicare-beneficiaries2 of 2
cms.gov/newsroom/press-releases/hhs-announces-15-additional-drugs-selected-medicare-drug-price-negotiations-continued-effort-lower3 of 3
cms.gov/priorities/innovation/innovation-models/balance5 of 5
cobi-ws.utah.gov/api/tab/issues/detail/2025/1/23793.json1 of 1
cobi-ws.utah.gov/api/tab/issues/detail/2026/1/25486.json2 of 2
cobyhealth.com/6 of 6
cobyhealth.com/help4 of 4
cobyhealth.com/treatments/weight-loss/semaglutide2 of 2
cobyhealth.com/treatments/weight-loss/tirzepatide2 of 2
codes.ohio.gov/ohio-administrative-code/rule-5160-9-032 of 2
connect.bcbsil.com/health-and-wellness/b/weblog/posts/weight-loss-options2 of 2
consumer.ftc.gov/articles/truth-behind-weight-loss-ads6 of 6
content.govdelivery.com/accounts/MODSS/bulletins/3f4823a6 of 6
contenthub-aem.optumrx.com//graphql/execute.json/retail-pharmacy-override/getsdpdlcontent3 of 3
corporate.walmart.com/about/samsclub/news/2026/01/07/as-new-year-wellness-goals-take-shape-sams-club-helps-members-navigate-the-first-and-only-oral-glp-1-option3 of 3
costco.com/member-prescription-program.html1 of 1
ctdssmap.com/CTPortal/Pharmacy-Information4 of 4
cvs.com/content/weight-loss4 of 4
cvs.com/minuteclinic/services/weight-loss-program9 of 9
cvs.com/minuteclinic/virtual-care1 of 1
cvshealth.com/news/company-news/cvs-health-enhances-its-direct-to-consumer-weight-management-offerings.html2 of 2
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da9839 of 39
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b92 of 92
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c6262 of 62
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d7947 of 47
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc046 of 46
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b163 of 163
data.capitol.hawaii.gov/session/measure_indiv.aspx?billtype=HB&billnumber=2456&year=20261 of 1
data.capitol.hawaii.gov/sessions/session2026/bills/HB2456_HD1_.HTM3 of 3
dc-pbm.com/provider-forms3 of 3
dhcf.dc.gov/service/right-rx-initiative1 of 1
dhhs.ne.gov/Pages/Medicaid-Provider-Pharmacy-Services.aspx1 of 1
dhhs.ne.gov/Pages/Medicaid-Services.aspx1 of 1
dhss.delaware.gov/dmma/1 of 1
docs.startwillow.com/en/articles/8838990-is-willow-covered-by-insurance2 of 2
dss.mo.gov/mhd/bulletins/morx-policy-regarding-cms-glp-1-bridge-demonstration-program-copayments1 of 1
dss.mo.gov/mhd/hot-tips/biopsychosocial-treatment-obesity1 of 1
dss.mo.gov/mhd/pharmacy2 of 2
dss.mo.gov/mhd/pharmacy-clinical-edits-pdl?pce=GLP2 of 2
dss.sd.gov/medicaid/providers/pa/1 of 1
dvha.vermont.gov/forms-manuals/forms/pharmacy-prior-authorization-request-forms-and-order-forms3 of 3
effecty.com/4 of 4
effecty.com/faq4 of 4
effecty.com/weight-loss/compounded-semaglutide3 of 3
effecty.com/weight-loss/compounded-tirzepatide2 of 2
effecty.com/weight-loss/wegovy2 of 2
effecty.com/weight-loss/zepbound2 of 2
ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-8-11-april-20242 of 2
enhance.md/faq8 of 8
enhance.md/product/advanced-tirzepatide1 of 1
enhance.md/product/core-semaglutide4 of 4
enhance.md/product/elite-tirzepatide-and-semaglutide1 of 1
enhance.md/shipping-returns1 of 1
ersnet.org/news-and-features/news/weight-loss-injection-semaglutide-can-reduce-asthma-attacks-by-up-to-40-per-cent/7 of 7
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=27633186&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=28110911&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=32379652&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=33567185&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=33755728&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=34170647&rettype=abstract&retmode=text5 of 5
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=34186022&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=35441470&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=35658024&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=36066977&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=36216945&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=36322838&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=37541662&rettype=abstract&retmode=text3 of 3
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=37952131&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=38017205&rettype=abstract&retmode=text3 of 3
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=38078870&rettype=abstract&retmode=text5 of 5
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=38206146&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=38536176&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=38740993&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=38778151&rettype=abstract&retmode=text3 of 3
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=38785209&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=38856224&rettype=abstract&retmode=text5 of 5
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=38874170&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=38912654&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39536238&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39555826&rettype=abstract&retmode=text6 of 6
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39556360&rettype=abstract&retmode=text7 of 7
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39937469&rettype=abstract&retmode=text5 of 5
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39996356&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=40305708&rettype=abstract&retmode=text3 of 3
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=40353578&rettype=abstract&retmode=text6 of 6
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=40407186&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=40450457&rettype=abstract&retmode=text4 of 4
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=40626110&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=40934115&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=40960239&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=40961952&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=41022371&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=41291666&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=41310257&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=41406444&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=41701618&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=41998799&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=42005929&rettype=abstract&retmode=text3 of 3
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=42517362&rettype=abstract&retmode=text2 of 2
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=42647098&rettype=abstract&retmode=text1 of 1
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=42730869&rettype=abstract&retmode=text3 of 3
eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=42764399&rettype=abstract&retmode=text2 of 2
events.in.gov/event/governor-braun-announces-state-medicaid-program-will-now-cover-glp-1-treatments-for-eligible-beneficiaries3 of 3
evernorth.com/articles/evernorth-launches-new-benefit-option-drives-lower-net-cost-weight-loss-medicines1 of 1
evernorth.com/encirclerx-provider4 of 4
express-scripts.com/enguidepharmacy/help/frequently-asked-questions1 of 1
express-scripts.com/frequently-asked-questions/are-glp-1s-or-semaglutide-covered-my-plan2 of 2
fda.gov/consumers/consumer-updates/fda-101-dietary-supplements6 of 6
fda.gov/consumers/consumer-updates/it-really-fda-approved1 of 1
fda.gov/drugs/development-approval-process-drugs/frequently-asked-questions-patents-and-exclusivity2 of 2
fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize15 of 15
fda.gov/drugs/drug-alerts-and-statements/fda-warns-consumers-not-use-counterfeit-ozempic-semaglutide-found-us-drug-supply-chain5 of 5
fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss26 of 26
fda.gov/drugs/drug-approvals-and-databases/drugsfda-glossary-terms1 of 1
fda.gov/drugs/drug-safety-communications/fda-requests-removal-suicidal-behavior-and-ideation-warning-glucagon-peptide-1-receptor-agonist-glp8 of 8
fda.gov/drugs/drug-safety-communications/update-fdas-ongoing-evaluation-reports-suicidal-thoughts-or-actions-patients-taking-certain-type2 of 2
fda.gov/drugs/drug-shortages/frequently-asked-questions-about-drug-shortages2 of 2
fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers8 of 8
fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded11 of 11
fda.gov/drugs/human-drug-compounding/fda-telehealth-companies-what-know-when-promoting-compounded-drugs3 of 3
fda.gov/drugs/human-drug-compounding/information-outsourcing-facilities2 of 2
fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities1 of 1
fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss1 of 1
fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medicamentos-que-contienen-semaglutida-comercializados-para-la-diabetes-de-tipo-2-o-la-perdida-de1 of 1
fda.gov/food/nutrition-education-resources-materials/sodium-your-diet3 of 3
fda.gov/food/nutrition-food-labeling-and-critical-foods/structurefunction-claims1 of 1
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/online-advisory-letters6 of 6
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/about-warning-and-close-out-letters1 of 1
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amazoncom-inc-662503-122020231 of 1
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aspen-aesthetics-dba-fifty-410-721481-022020263 of 3
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/belle-health-llc-dba-belle-721795-022020262 of 2
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cvs-health-663246-091120231 of 1
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eden-health-international-inc-dba-eden-728279-060820265 of 5
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fitrx-llc-dba-am-rx-728275-060820262 of 2
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fitrx-llc-dba-fitrx-717987-022020262 of 2
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fitrx-llc-dba-zealthy-716501-090920253 of 3
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/formpour-722215-033120263 of 3
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hims-hers-health-inc-dba-hers-716825-090920251 of 1
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hims-hers-health-inc-dba-hims-716567-090920254 of 4
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ivim-services-llc-dba-ivim-721816-022020262 of 2
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lean-rx-inc-dba-skinnyrx-717989-022020264 of 4
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/levity-inc-dba-levity-717990-022020263 of 3
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/maximus-health-inc-dba-maximus-730095-060820263 of 3
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medvi-llc-dba-medvi-721455-022020264 of 4
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/orderlymeds-llc-dba-orderlymeds-728291-060820263 of 3
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/prorx-llc-723704-040720262 of 2
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/remedy-meds-716830-090920253 of 3
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/strut-health-llc-dba-strut-721448-022020265 of 5
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/usapeptidecom-696885-022620253 of 3
fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/walgreens-boots-alliance-inc-663404-091120231 of 1
fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea2 of 2
fda.gov/news-events/press-announcements/fda-approves-first-new-molecular-entity-under-national-priority-voucher-program3 of 3
fda.gov/news-events/press-announcements/fda-approves-first-treatment-patients-liver-scarring-due-fatty-liver-disease1 of 1
fda.gov/news-events/press-announcements/fda-approves-fourth-product-under-national-priority-voucher-program-higher-dose-semaglutide3 of 3
fda.gov/news-events/press-announcements/fda-intends-take-action-against-non-fda-approved-glp-1-drugs3 of 3
fda.gov/news-events/press-announcements/fda-launches-green-list-protect-americans-illegal-imported-glp-1-drug-ingredients1 of 1
fda.gov/news-events/press-announcements/fda-proposes-exclude-semaglutide-tirzepatide-and-liraglutide-503b-bulks-list3 of 3
fda.gov/news-events/press-announcements/fda-warns-30-telehealth-companies-against-illegal-marketing-compounded-glp-1s5 of 5
federalregister.gov/documents/2024/12/10/2024-27939/medicare-and-medicaid-programs-contract-year-2026-policy-and-technical-changes-to-the-medicare-advantage-program2 of 2
fellahealth.com/3 of 3
fellahealth.com/affiliate-program1 of 1
fellahealth.com/faq1 of 1
fellahealth.com/faq/insurance1 of 1
fellahealth.com/faq/popular-questions2 of 2
fellahealth.com/guarantee3 of 3
fellahealth.com/membership-terms4 of 4
fellahealth.com/treatments2 of 2
fellahealth.com/your-plan6 of 6
fepblue.org/faqs/faq-pharmacy8 of 8
fepblue.org/manage-your-health/managing-specific-conditions/weight1 of 1
fepblue.org/pharmacy/prescriptions3 of 3
fifty410.com/2 of 2
fifty410.com/faq2 of 2
fifty410.com/pricing7 of 7
fifty410.com/refund-policy1 of 1
floridablue.com/answers/all-about-care/understanding-your-prescription-drug-coverage2 of 2
floridablue.com/medicare/education/part-d1 of 1
floridablue.com/members/tools-resources/faq/pharmacy-faqs1 of 1
floridablue.com/members/tools-resources/pharmacy/medication-guide1 of 1
floridablue.com/providers/news/bulletins-and-faqs1 of 1
flsenate.gov/Session/Bill/2025/6482 of 2
formhealth.co/faqs16 of 16
formhealth.co/legal/terms-of-use3 of 3
formhealth.co/weight-loss-medications2 of 2
forwardhealth.wi.gov/WIPortal/Subsystem/KW/Print.aspx?c=11&ia=1&p=1&s=3&sa=481 of 1
forwardhealth.wi.gov/WIPortal/Subsystem/KW/Print.aspx?c=345&ia=1&p=1&s=3&sa=482 of 2
forwardhealth.wi.gov/WIPortal/Subsystem/KW/Print.aspx?ia=1&p=1&sa=48&s=3&c=11&nt=Wegovy+Injection+and+Wegovy+Tablets&adv=Y3 of 3
forwardhealth.wi.gov/WIPortal/Subsystem/KW/Print.aspx?ia=1&p=1&sa=48&s=3&c=345&nt=Weight+Management+Agents&adv=Y4 of 4
foundayo.lilly.com/2 of 2
ftc.gov/business-guidance/advertising-marketing/health-claims1 of 1
ftc.gov/business-guidance/resources/ftcs-endorsement-guides-what-people-are-asking8 of 8
ftc.gov/business-guidance/resources/gut-check-reference-guide-media-spotting-false-weight-loss-claims2 of 2
ftc.gov/news-events/news/press-releases/2024/08/federal-trade-commission-announces-final-rule-banning-fake-reviews-testimonials3 of 3
gc.nh.gov/bill_status/legacy/bs2016/bill_docket.aspx?lsr=2204&sy=2026&sortoption=&txtsessionyear=2026&txtbillnumber=SB4551 of 1
gc.nh.gov/bill_status/legacy/bs2016/billText.aspx?sy=2026&id=1403&txtFormat=html1 of 1
getzealthy.com/1 of 1
getzealthy.com/faqs1 of 1
getzealthy.com/subscriptions-cancellations-refunds-policy2 of 2
getzealthy.com/weight-loss-faq7 of 7
gimme.care/9 of 9
gimme.care/policies/refund-policy3 of 3
gimme.care/policies/terms-of-service1 of 1
glp1.medvi.org/4 of 4
go.getzealthy.com/zealthy-weight-loss-pricing_homepage/4 of 4
gobymeds.com/11 of 11
gobymeds.com/getting-started/pricing9 of 9
goodrx.com/care/services/glp-1-weight-loss11 of 11
goodrx.com/classes/glp-1-agonists/glp-1-drugs-cost-and-savings1 of 1
goodrx.com/go/ed-care-terms4 of 4
gov.uk/government/news/mhra-finds-evidence-does-not-support-a-link-between-glucagon-like-peptide-1-glp-1-receptor-agonists-and-suicidal-and-self-injurious-thoughts-and-act2 of 2
hca.nm.gov/preferred-drug-list/1 of 1
hca.nm.gov/weight-reduction-medications/5 of 5
hca.wa.gov/billers-providers-partners/program-information-providers/apple-health-medicaid-drug-coverage-criteria3 of 3
hcpf.colorado.gov/pharmacy-benefits2 of 2
hcpf.colorado.gov/pharmacy-billing-manual2 of 2
health.alaska.gov/en/education/prior-authorization-medication/1 of 1
health.amazon.com/onemedical/public/weight-loss/glp-1-weight-loss4 of 4
health.maryland.gov/mmcp/pap/pages/clinical-criteria.aspx1 of 1
health.maryland.gov/mmcp/pap/Pages/paphome.aspx1 of 1
health.maryland.gov/mmcp/provider/_api/web/lists/GetByTitle('Provider-Transmittals')/items?$top=50003 of 3
health.ny.gov/health_care/medicaid/program/update/2025/no01_2025-01.htm3 of 3
health.ny.gov/health_care/medicaid/program/update/2025/no04_2025-04.htm1 of 1
health.ny.gov/health_care/medicaid/redesign/mrt2/pharmacy_transition/pharmacy_transition_faq.htm1 of 1
health.wyo.gov/healthcarefin/medicaid/pharmacy-services/medicaidpharmacy/1 of 1
healthandwelfare.idaho.gov/providers/pharmacy-providers/idaho-medicaid-pharmacy-program1 of 1
healthcare.gov/appeal-insurance-company-decision/external-review/3 of 3
healthcare.gov/appeal-insurance-company-decision/internal-appeals/4 of 4
healthcare.gov/choose-a-plan/comparing-plans/2 of 2
healthcare.gov/coverage/what-marketplace-plans-cover/3 of 3
healthcare.gov/glossary/appeal/2 of 2
healthcare.gov/glossary/brand-name-drugs/1 of 1
healthcare.gov/glossary/co-insurance/2 of 2
healthcare.gov/glossary/co-payment/2 of 2
healthcare.gov/glossary/deductible/2 of 2
healthcare.gov/glossary/external-review/1 of 1
healthcare.gov/glossary/flexible-spending-account-fsa/1 of 1
healthcare.gov/glossary/formulary/1 of 1
healthcare.gov/glossary/generic-drugs/1 of 1
healthcare.gov/glossary/health-savings-account-hsa/1 of 1
healthcare.gov/glossary/out-of-pocket-maximum-limit/2 of 2
healthcare.gov/glossary/preauthorization/1 of 1
healthcare.gov/glossary/prescription-drug-coverage/1 of 1
healthcare.gov/glossary/prescription-drugs/1 of 1
healthcare.gov/glossary/prior-authorization/1 of 1
healthcare.gov/using-marketplace-coverage/prescription-medications/2 of 2
healthy.kaiserpermanente.org/health-wellness/drug-formulary/how-it-works4 of 4
healthy.kaiserpermanente.org/health-wellness/health-encyclopedia/he.weight-loss-medicines.abq51862 of 2
helloalpha.com/membership5 of 5
helloalpha.com/prescription-philosophy2 of 2
helloalpha.com/terms2 of 2
helloalpha.com/weight-loss8 of 8
help.9am.health/api/v2/help_center/en-us/articles/14125762984603.json1 of 1
help.9am.health/api/v2/help_center/en-us/articles/32333170418459.json1 of 1
help.9am.health/api/v2/help_center/en-us/articles/4415328668443.json1 of 1
help.fifty410.com/en/articles/10249499-states-we-cover1 of 1
help.formhealth.co/article/256-id-like-to-cancel-pause-my-account2 of 2
help.formhealth.co/article/32-why-do-i-owe-an-additional-balance-when-i-already-pay-99-month2 of 2
help.formhealth.co/article/482-do-you-prescribe-compounded-medication1 of 1
help.formhealth.co/article/484-are-there-any-clinicians-in-my-area1 of 1
help.invigormedical.com/en/articles/9294008-can-i-cancel-my-subscription-at-any-time3 of 3
help.invigormedical.com/en/articles/9294023-do-you-accept-medical-insurance1 of 1
help.invigormedical.com/en/articles/9294098-do-you-ship-to-other-countries2 of 2
help.invigormedical.com/en/articles/9295011-will-my-subscription-automatically-renew1 of 1
help.invigormedical.com/en/articles/9312241-can-i-clarify-the-cost-of-a-medication-or-treatment-that-i-ordered1 of 1
help.invigormedical.com/en/articles/9319373-i-have-a-question-about-the-medication2 of 2
help.joinbelle.com/en/articles/16648651-cancelling-your-subscription2 of 2
help.joinbelle.com/en/articles/16648666-does-belle-ship-outside-the-united-states1 of 1
help.joinbelle.com/en/articles/16648678-glp-1-plans-shipments-and-billing-how-it-works1 of 1
help.joinpolly.com/en/articles/14718584-is-there-a-membership-fee1 of 1
help.joinpolly.com/en/articles/14718601-do-the-multi-month-plans-bill-monthly-or-upfront-and-are-they-refundable2 of 2
help.joinpolly.com/en/articles/14718608-what-is-your-monthly-dose-change-price-for-compounded-semaglutide2 of 2
help.joinpolly.com/en/articles/14718621-what-is-your-monthly-dose-change-price-for-compounded-tirzepatide2 of 2
help.remedymeds.com/en/categories/568641-billing1 of 1
help.senate.gov/dem/newsroom/press/news-chairman-sanders-launches-investigation-into-outrageously-high-price-of-ozempic-and-wegovy-in-the-united-states1 of 1
help.sesamecare.com/api/v2/help_center/en-us/articles/40165221309716.json4 of 4
henrymeds.com/faq2 of 2
henrymeds.com/landing/glp-11 of 1
henrymeds.com/treatments/weight-management/glp-1-weight-management6 of 6
henrymeds.com/treatments/weight-management/semaglutide3 of 3
henrymeds.com/treatments/weight-management/tirzepatide-tablets1 of 1
hfs.illinois.gov/medicalproviders/notices/notice.prn260521b.html4 of 4
hfs.illinois.gov/medicalproviders/notices/notice.prn260910a.html7 of 7
hfs.illinois.gov/medicalproviders/pharmacy.html1 of 1
hhs.iowa.gov/medicaid/provider-services/medicaid-pharmacy2 of 2
hhs.nd.gov/healthcare/medicaid/provider/communications/newsletters/nd-medicaid-provider-newsletter-december-20231 of 1
hhs.nd.gov/healthcare/medicaid/provider/communications/newsletters/nd-medicaid-provider-newsletter-june-20241 of 1
hhs.nd.gov/medicaid-member-engagement/news2 of 2
highmark.com/employer/thought-leadership/health-insurance-cost-management/noom-weight-management1 of 1
highmark.com/member/bcbs/medical-drug-formulary4 of 4
hioscar.com/for-members1 of 1
hioscar.com/for-providers/clinical-guidelines/pharmacy9 of 9
home.medvi.org/3 of 3
home.medvi.org/cancellation-and-refund-policy4 of 4
home.medvi.org/terms-and-conditions2 of 2
honehealth.com/liraglutide/3 of 3
honehealth.com/mens/weight-loss/5 of 5
honehealth.com/terms/4 of 4
house.mn.gov/SessionDaily/Story/190333 of 3
humana.com/medicare/medicare-resources/does-medicare-cover-weight-loss-drugs9 of 9
humana.com/pharmacy/medicare-drug-list2 of 2
humanservices.arkansas.gov/divisions-shared-services/medical-services/1 of 1
huskyhealthct.org/providers/provider_updates.html5 of 5
ibx.com/get-care/prescription-drug-information/find-a-covered-prescription-drug.html2 of 2
ilga.gov/commission/jcar/admincode/089/089001400D04410R.html1 of 1
ilpriorauth.com/pages/141 of 1
in.gov/medicaid/members/member-programs/pharmacy-benefits/1 of 1
in.gov/medicaid/providers/clinical-services/pharmacy-benefits/1 of 1
in.gov/medicaid/providers/provider-references/bulletins-banner-pages-and-reference-modules/ihcp-bulletins/1 of 1
investors.cvshealth.com/news/news-details/2025/CVS-HEALTH-CORPORATION-REPORTS-FIRST-QUARTER-2025-RESULTS-AND-UPDATES-FULL-YEAR-2025-GUIDANCE/default.aspx2 of 2
iowamedicaidpdl.com/pa-pdl/pa-forms.html1 of 1
irs.gov/individuals/frequently-asked-questions-about-medical-expenses-related-to-nutrition-wellness-and-general-health2 of 2
irs.gov/publications/p5026 of 6
irs.gov/publications/p9692 of 2
irs.gov/taxtopics/tc5021 of 1
ivimhealth.com/1 of 1
ivimhealth.com/glp1idwt/4 of 4
ivimhealth.com/refund_returns/1 of 1
ivimhealth.com/terms-and-conditions/3 of 3
ivimhealth.com/wegovypill/4 of 4
ivimhealth.com/zepbound/1 of 1
ivyrx.com/products/mounjaro1 of 1
ivyrx.com/products/ozempic1 of 1
ivyrx.com/products/personalized-glp-1-injections3 of 3
ivyrx.com/terms-of-service1 of 1
ivyrx.com/weight-loss1 of 1
join9am.com/amazon2 of 2
join9am.com/for-individuals3 of 3
join9am.com/metformin3 of 3
join9am.com/terms-of-service2 of 2
joinamble.com/faq4 of 4
joinamble.com/glp-1-injections5 of 5
joinamble.com/terms-of-service4 of 4
joinbelle.com/2 of 2
joinbelle.com/faq3 of 3
joinbelle.com/treatments6 of 6
joinbelle.com/treatments/weight-loss/compounded-semaglutide1 of 1
joincalibrate.com/faqs4 of 4
joincalibrate.com/legal/guarantee6 of 6
joincalibrate.com/legal/membership-terms-and-conditions7 of 7
joincalibrate.com/pricing14 of 14
joinfound.com2 of 2
joinfound.com/glp1-checker1 of 1
joinfound.com/plans-and-pricing9 of 9
joinfound.com/program2 of 2
joinfound.com/terms/offer-terms-v315 of 15
joinfound.com/terms/terms-and-conditions8 of 8
joinfridays.com/faqs5 of 5
joinfridays.com/pricing7 of 7
joinfridays.com/terms-conditions5 of 5
joinfridays.com/1 of 1
joinlevity.com/4 of 4
joinlevity.com/service-unavailable5 of 5
joinlevity.com/terms1 of 1
joinmochi.com/10 of 10
joinmochi.com/faqs8 of 8
joinmochi.com/medications/foundayo1 of 1
joinmochi.com/medications/zepbound1 of 1
joinmochi.com/termsandconditions5 of 5
joinpolly.com/5 of 5
joinpolly.com/refund-policy2 of 2
joinpomegranate.com/faqs1 of 1
joinpomegranate.com/products/compounded-semaglutide4 of 4
joinpomegranate.com/products/compounded-tirzepatide1 of 1
joinpomegranate.com/products/wegovy-r-semaglutide-oral2 of 2
joinpomegranate.com/services/weight-loss1 of 1
joinpomegranate.com/subscription-terms4 of 4
joinpomegranate.com/terms-of-service1 of 1
kdhe.ks.gov/1762/Class-Specific-Clinical-Criteria4 of 4
kdhe.ks.gov/188/Pharmacy1 of 1
kff.org/health-costs/2025-employer-health-benefits-survey/11 of 11
kff.org/health-costs/annual-family-premiums-for-employer-coverage-rise-6-in-2025-nearing-27000-with-workers-paying-6850-toward-premiums-out-of-their-paychecks/2 of 2
kff.org/health-costs/kff-health-tracking-poll-may-2024-the-publics-use-and-views-of-glp-1-drugs/2 of 2
kff.org/public-opinion/kff-health-tracking-poll-prescription-drug-costs-views-on-trump-administration-actions-and-glp-1-use/11 of 11
knownwell.co/faqs19 of 19
knownwell.co/weight-loss-medication-pricing10 of 10
kyportal.medimpact.com/provider-documents/drug-information2 of 2
kyportal.medimpact.com/provider-documents/pharmacy-memos-and-newsletters1 of 1
lamedicaid.com/provweb1/pharmacy/pharmacyindex.htm2 of 2
lao.ca.gov/Publications/Report/50753 of 3
lao.ca.gov/Publications/Report/51461 of 1
laskerfoundation.org/winners/glp-1-based-therapy-for-obesity/10 of 10
lavenderskyhealth.com/faq/2 of 2
lavenderskyhealth.com/service-pricing-lavender-sky-health/5 of 5
lavenderskyhealth.com/treatment-plan-pricing/10 of 10
ldh.la.gov/medicaid/managed-care-pharmacy-and-medical-drug-policies-archive-20251 of 1
ldh.la.gov/medicaid/medicaid-services2 of 2
leg.state.nv.us/App/NELIS/REL/83rd2025/Bill/FillSelectedBillTab?selectedTab=Overview&billKey=123663 of 3
legis.la.gov/legis/BillInfo.aspx?s=26RS&b=SB433&sbi=y2 of 2
legislature.mi.gov/documents/2025-2026/publicact/htm/2025-PA-0022.htm3 of 3
legislature.mi.gov/documents/2025-2026/publicact/htm/2026-PA-0021.htm2 of 2
legislature.vermont.gov/bill/status/2024/H.7651 of 1
lemmelive.com/pages/faq1 of 1
lemmelive.com/products/lemme-glp-19 of 9
lemonaidhealth.com/legals/cancellation-policy1 of 1
lemonaidhealth.com/legals/refund-policy1 of 1
lemonaidhealth.com/services/weight-loss12 of 12
lifemd.com/faq/2 of 2
lifemd.com/terms1 of 1
lifemd.com/weight-management/13 of 13
liferx.md/returns-policy1 of 1
liferx.md/terms-of-use2 of 2
liferx.md/weight-loss7 of 7
lilly.com/about/contact3 of 3
lilly.com/lillydirect4 of 4
lilly.com/lillydirect/foundayo12 of 12
lilly.com/lillydirect/foundayo/foundayo-full-terms-conditions11 of 11
lilly.com/lillydirect/mounjaro8 of 8
lilly.com/lillydirect/mounjaro/mounjaro-purchase-terms1 of 1
lilly.com/lillydirect/rx-support2 of 2
lilly.com/lillydirect/zepbound42 of 42
lilly.com/lillydirect/zepbound/zepbound-tirzepatide-full-terms-conditions21 of 21
lilly.com/news/media/mounjaro1 of 1
maine.gov/dhhs/oms/mainecare-options/covered-services-benefits1 of 1
mainecarepdl.org/content/mainecarepdl/en/prior-authorization-forms.html1 of 1
maximustribe.com/glp-1/wegovy-tablets1 of 1
maximustribe.com/terms-of-use1 of 1
maximustribe.com/weight-loss10 of 10
maximustribe.com/weight-loss/semaglutide-standard1 of 1
maximustribe.com/weight-loss/tirzepatide-standard4 of 4
medicaid.alabama.gov/alert_detail.aspx?ID=167653 of 3
medicaid.alabama.gov/alert_detail.aspx?ID=168072 of 2
medicaid.alabama.gov/content/12.0_Archive/alert_detail_archived.aspx?ID=166743 of 3
medicaid.alabama.gov/content/4.0_Programs/4.3_Pharmacy-DME/4.3.7_Preferred_Drug_List.aspx1 of 1
medicaid.georgia.gov/https:/dch.georgia.gov/providers/medicaid-pharmacy1 of 1
medicaid.ms.gov/ms-spa-23-0013-drugs-to-treat-obesity-approved-by-cms/2 of 2
medicaid.ms.gov/pharmacy-prior-authorization/3 of 3
medicaid.ms.gov/preferred-drug-list-2/5 of 5
medicaid.ncdhhs.gov/blog/2025/09/05/nc-medicaid-change-coverage-glp-1-weight-management-medications3 of 3
medicaid.ncdhhs.gov/blog/2025/12/19/nc-medicaid-reinstitute-coverage-glp-1s-weight-management9 of 9
medicaid.utah.gov/pharmacy-program/prior-authorization/2 of 2
medicaidprovider.mt.gov/191 of 1
medicaidprovider.mt.gov/manuals/prescriptiondrugprogrammanual2 of 2
medicare.gov/coverage/weight-loss-drugs14 of 14
medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work6 of 6
medicare.premera.com/medicare-advantage/1 of 1
medlineplus.gov/clinicaltrials.html3 of 3
medlineplus.gov/druginfo/meds/a618008.html1 of 1
medlineplus.gov/ency/article/000158.htm1 of 1
medlineplus.gov/ency/article/002467.htm2 of 2
medlineplus.gov/ency/article/003088.htm6 of 6
medlineplus.gov/ency/article/003117.htm1 of 1
medlineplus.gov/ency/article/003246.htm6 of 6
medlineplus.gov/ency/patientinstructions/000120.htm6 of 6
medlineplus.gov/ency/patientinstructions/000121.htm5 of 5
medlineplus.gov/ency/patientinstructions/000122.htm6 of 6
medquest.hawaii.gov/en/plans-providers/pharmacy/drug-coverage.html1 of 1
medquest.hawaii.gov/en/plans-providers/pharmacy/drug-coverage/pa-criteria.html1 of 1
medvidi.com/1 of 1
medvidi.com/about-us/refund-policy/2 of 2
medvidi.com/blog/how-to-get-wegovy2 of 2
medvidi.com/faqs/2 of 2
medvidi.com/services/weight-loss-treatment/6 of 6
member.carefirst.com/members/drug-pharmacy-information/drug-search.page1 of 1
mgaleg.maryland.gov/mgawebsite/Legislation/Details/sb0496?ys=2026RS2 of 2
mhdl.pharmacy.services.conduent.com/MHDL/pubintro.do?category=Introduction+to+MassHealth+Drug+List1 of 1
mhdl.pharmacy.services.conduent.com/MHDL/pubtheradetail.do?id=264 of 4
mhdl.pharmacy.services.conduent.com/MHDL/pubtheradetail.do?id=3085&drugId=86717 of 7
michigan.gov/mdhhs/doing-business/providers/providers/billingreimbursement/pharmacy1 of 1
michigan.gov/mdhhs/doing-business/providers/providers/medicaid/policyforms/2025-medicaid-provider-l-letters1 of 1
militaryrx.express-scripts.com/blog/changes-your-tricare-pharmacy-benefit5 of 5
militaryrx.express-scripts.com/blog/how-do-i-know-if-my-medication-covered-tricare1 of 1
militaryrx.express-scripts.com/faq/GLP-1-medications-diabetes-weight-management7 of 7
molinahealthcare.com/marketplace/nv/en-us/Providers/Drug-List2 of 2
molinahealthcare.com/members/tx/en-US/mem/medicare/drug/drug1 of 1
molinahealthcare.com/providers/il/medicaid/drug/formulary.aspx3 of 3
molinahealthcare.com/providers/va/medicaid/resources/forms.aspx2 of 2
molinamarketplace.com/providers/ky/medicaid/comm/newsarticlepage.aspx?ArticleID=259%20eNews%20GLP1%20Criteria%20Change&lob=&type=IsNewsMediaSpecial&year=All&State=ALL&ArticlePageLink=/providers/ky/medicaid/comm/newsarticlepage.aspx5 of 5
mounjaro.lilly.com/2 of 2
mounjaro.lilly.com/savings-coverage12 of 12
mounjaro.lilly.com/what-is-mounjaro1 of 1
my-bmi.co.uk/4 of 4
my-bmi.co.uk/about-us1 of 1
my-bmi.co.uk/delivery3 of 3
my-bmi.co.uk/wegovy/wegovy-prices3 of 3
nature.com/articles/s41586-026-10940-712 of 12
nccih.nih.gov/health/berberine-and-weight-loss-what-you-need-to-know6 of 6
nccih.nih.gov/health/in-the-news-berberine1 of 1
ndlegis.gov/assembly/69-2025/regular/bill-overview/bo1451.html2 of 2
nebraska.fhsc.com/priorauth/paforms.asp1 of 1
nevadamedicaid.nv.gov/1 of 1
news.gallup.com/poll/712157/glp-usage-reaches-new-high.aspx4 of 4
news.hims.com/newsroom/full-range-of-fda-approved-glp-1s-available-on-hims-hers1 of 1
news.hims.com/newsroom/hims-hers-introduces-6-month-wegovy-r-new-customer-offer2 of 2
news.hims.com/newsroom/wegovy-r-pill-and-wegovy-r-pen-now-available-with-hims-hers10 of 10
news.iu.edu/kinseyinstitute/live/news/46263-survey-shows-glp-1-weight-loss-drugs-are-changing6 of 6
newsroom.cigna.com/all-stories?item=5622 of 2
newsroom.cigna.com/all-stories?item=6893 of 3
nhmmis.nh.gov/portals/wps/portal/MessagesAnnouncementsForPublic2 of 2
nia.nih.gov/health/clinical-trials-and-studies/what-are-clinical-trials-and-studies15 of 15
niaaa.nih.gov/alcohols-effects-health/alcohols-effects-body1 of 1
niaaa.nih.gov/news-events/spectrum/volume-16-issue-1-winter-2024/semaglutide-shows-promise-potential-alcohol-use-disorder-medication2 of 2
nichd.nih.gov/health/topics/pcos/conditioninfo2 of 2
nichd.nih.gov/health/topics/pcos/conditioninfo/treatments2 of 2
niddk.nih.gov/health-information/diabetes/overview/preventing-problems/low-blood-glucose-hypoglycemia2 of 2
niddk.nih.gov/health-information/digestive-diseases/constipation/eating-diet-nutrition1 of 1
niddk.nih.gov/health-information/digestive-diseases/constipation/treatment2 of 2
niddk.nih.gov/health-information/digestive-diseases/diarrhea/eating-diet-nutrition2 of 2
niddk.nih.gov/health-information/digestive-diseases/diarrhea/treatment4 of 4
niddk.nih.gov/health-information/digestive-diseases/gas-digestive-tract/symptoms-causes4 of 4
niddk.nih.gov/health-information/digestive-diseases/gas-digestive-tract/treatment3 of 3
niddk.nih.gov/health-information/liver-disease/nafld-nash/definition-facts2 of 2
niddk.nih.gov/health-information/weight-management/adult-overweight-obesity/clinical-trials3 of 3
niddk.nih.gov/health-information/weight-management/healthy-eating-physical-activity-for-life/health-tips-for-adults4 of 4
niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity2 of 2
niddk.nih.gov/news/archive/2021/story-discovery-medications-diabetes-obesity-emerged-research-pancreatic-hormone5 of 5
nj.gov/humanservices/dmahs/news-publications/overview/2 of 2
noom.com/med/glp-1rx/2 of 2
noom.com/med/glp1-microdose/2 of 2
noom.com/med/pricing/7 of 7
noom.com/med/zepbound/1 of 1
noom.com/medicare-bridge/3 of 3
noom.com/support/faqs/programs/2025/10/noom-refund-policy/2 of 2
noom.com/support/faqs/programs/noom-med-programs/telehealth-for-branded-meds/2025/10/contacting-a-telehealth-clinician/1 of 1
noom.com/support/faqs/programs/noom-med-programs/telehealth-for-branded-meds/2025/10/how-does-the-telehealth-for-branded-meds-program-work/2 of 2
noom.com/support/faqs/programs/noom-med-programs/telehealth-for-branded-meds/2025/10/labs-in-the-telehealth-for-branded-meds-program/2 of 2
noom.com/support/faqs/programs/noom-med-programs/telehealth-for-branded-meds/2025/10/telehealth-for-branded-meds-prescriptions/3 of 3
noom.com/support/faqs/subscription-and-billing/2025/10/how-to-cancel-your-noom-subscription-or-trial/2 of 2
noom.com/support/faqs/subscription-and-billing/2025/10/how-to-upgrade-to-noom-med-program/1 of 1
noom.com/support/faqs/subscription-and-billing/2026/04/switching-your-noom-med-program/1 of 1
noom.com/terms-and-conditions-of-use/4 of 4
novocare.com/diabetes/help-with-costs/pap.html11 of 11
novocare.com/diabetes/products/ozempic.html1 of 1
novocare.com/diabetes/products/ozempic/savings-offer.html1 of 1
novocare.com/eligibility/diabetes-savings-card.html9 of 9
novocare.com/eligibility/pharmacy.html7 of 7
novocare.com/eligibility/wegovy-savings-card.html14 of 14
novocare.com/obesity/products/saxenda.html3 of 3
novocare.com/patient/medicines/wegovy.html1 of 1
novocare.com/patient/medicines/wegovy/savings-offer.html4 of 4
novocare.com/patient/treatment/find-doctor.html1 of 1
novocare.com/pharmacy/faqs.html4 of 4
novocare.com/pharmacy/ozempic.html4 of 4
novocare.com/pharmacy/wegovy.html18 of 18
novomedlink.com/semaglutide/patient-safety/semaglutide-faq.html1 of 1
novonordisk-us.com/media/news-archive/news-details.html?id=9164603 of 3
novonordisk-us.com/media/news-archive/news-details.html?id=9164761 of 1
novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=9163481 of 1
novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=9164163 of 3
novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=9164501 of 1
novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=9164724 of 4
novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=9165011 of 1
novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=9165122 of 2
novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=9165422 of 2
novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=9167656 of 6
novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=9167743 of 3
novonordisk.com/investors/financial-results.html1 of 1
oklahoma.gov/ohca/policies-and-rules/xpolicy/medical-providers-fee-for-service/individual-providers-and-specialties/pharmacies/drug-benefit.html1 of 1
oklahoma.gov/ohca/providers/types/pharmacy/prior-authorization/2026.html1 of 1
oklahoma.gov/ohca/providers/types/pharmacy/prior-authorization/2026/endocrine-diabeticse.html2 of 2
oklahoma.gov/ohca/providers/types/pharmacy/prior-authorization/2026/metabolic-disorders.html5 of 5
olis.oregonlegislature.gov/liz/2025R1/Measures/Overview/HB35172 of 2
onlinesemaglutide.org/1 of 1
opm.gov/healthcare-insurance/healthcare/plan-information/plans/BrochureJson?brochureNumber=71-005&year=20261 of 1
orderlymeds.com/2 of 2
orderlymeds.com/faqs/6 of 6
orderlymeds.com/pricing/4 of 4
orpdl.org/drugs/drugclass.php?cid=10312 of 2
orpdl.org/drugs/drugclass.php?cid=10573 of 3
ozempic.com/2 of 2
ozempic.com/faqs/ozempic-pen.html2 of 2
ozempic.com/ozempic-pen/dosing.html1 of 1
ozempic.com/ozempic-pill/dosing.html1 of 1
ozempic.com/savings-and-resources/save-on-ozempic.html3 of 3
pa.gov/agencies/dhs/departments-offices/omap-info/whats-new-at-omap1 of 1
pacodeandbulletin.gov/Display/pabull?file=/secure/pabulletin/data/vol55/55-52/1777.html7 of 7
pharmacy.amazon.com/dp/B09C947KVF2 of 2
pharmacy.amazon.com/dp/B0B3RQZKKJ1 of 1
pharmacy.amazon.com/dp/B0GD5CK3JN3 of 3
pharmacy.amazon.com/dp/B0GP27N9T33 of 3
pharmacy.amazon.com/dp/B0GVPXYFHV2 of 2
pharmacy.amazon.com/medicare-glp-1-bridge-program-details2 of 2
plushcare.com/how-it-works7 of 7
plushcare.com/membership2 of 2
plushcare.com/refund-policy2 of 2
plushcare.com/semaglutide-prescription1 of 1
plushcare.com/terms3 of 3
plushcare.com/wegovy-semaglutide-prescription2 of 2
plushcare.com/weight-loss8 of 8
plushcare.com/zepbound-tirzepatide-prescription2 of 2
pmc.ncbi.nlm.nih.gov/articles/PMC12612741/22 of 22
pmc.ncbi.nlm.nih.gov/articles/PMC12661421/2 of 2
policy.humana.com/news-and-resources/news-press/2023/humana-to-exit-employer-group-commercial-medical-products1 of 1
portal.ct.gov/governor/news/press-releases/2025/05-2025/governor-lamont-signs-declaration-enabling-the-continued-funding-of-medicaid-this-fiscal-year1 of 1
portal.ct.gov/HUSKY/Pharmacy2 of 2
premera.com/wa/employer/news/pharmacy/glp-1-medications/2 of 2
premera.com/wa/provider/news/medical-policies/policy-updates/2 of 2
premera.com/wa/provider/pharmacy/drug-search/rx-search/1 of 1
prnewswire.com/news-releases/lilly-and-us-government-agree-to-expand-access-to-obesity-medicines-to-millions-of-americans-302607652.html2 of 2
prnewswire.com/news-releases/lilly-calls-on-online-platforms-payment-companies-and-regulators-to-shut-down-the-illegal-retatrutide-black-market-302849551.html1 of 1
prnewswire.com/news-releases/lilly-reports-second-quarter-2026-financial-results-raises-full-year-guidance-and-highlights-continued-growth-and-pipeline-progress-302843165.html1 of 1
prnewswire.com/news-releases/lillys-triple-agonist-retatrutide-delivered-powerful-weight-loss-in-pivotal-phase-3-obesity-trial-302778859.html5 of 5
prnewswire.com/news-releases/lillys-triple-agonist-retatrutide-successful-in-two-additional-phase-3-obesity-trials-delivering-significant-improvements-in-weight-and-a1c-302832674.html2 of 2
prnewswire.com/news-releases/novo-nordisk-advances-cardiometabolic-pipeline-with-new-data-featuring-cagrisema-and-zenagamtide-at-the-american-diabetes-associations-2026-scientific-sessions-302783110.html2 of 2
producernews.premera.com/february-premera-formulary-newsletter/6 of 6
producernews.premera.com/give-clients-a-smarter-way-to-manage-glp-1-coverage-for-weight-management/4 of 4
producernews.premera.com/mapping-employer-priorities-to-glp-1-solutions/3 of 3
provcomm.ibx.com/pnc-ibc/news/Pages/Changes-coming-to-weight-loss-drug-coverage-benefits.aspx4 of 4
provcomm.ibx.com/pnc-ibc/news/Pages/IBX-to-end-Commercial-coverage-of-Zepbound-for-OSA.aspx4 of 4
provcomm.ibx.com/pnc-ibc/news/Pages/The-Medicare-GLP-1-Bridge_What-providers-need-to-know-.aspx4 of 4
provider.carefirst.com/providers/news/2023/07/coverage-reminders-for-glucagon-like-peptide-1/2 of 2
provider.carefirst.com/providers/news/2023/12/new-documentation-requirements-for-incretin-mimetics/1 of 1
provider.carefirst.com/providers/news/2025/06/carefirst-formulary-updates-effective-jul-1-2025/1 of 1
providernews.anthem.com/california/articles/weight-management-program-overview-241961 of 1
providernews.anthem.com/virginia/articles/prepare-prescriptions-for-the-medicare-bridge-program-323513 of 3
providers.highmark.com/communications-hub/news-and-updates/clinical-solutions-for-2026-noom-sud-specialty-care-additional-offerings.html2 of 2
providers.highmark.com/communications-hub/news-and-updates/medicare-glp-1-bridge-new-cms-program-for-certain-weight-loss-drugs.html5 of 5
providers.highmark.com/wholecare/wholecare-newsfeed/glp-1-agonist-changes.html1 of 1
pushhealth.com/drugs/glp-1-agonist3 of 3
pushhealth.com/drugs/ozempic1 of 1
pushhealth.com/drugs/zepbound1 of 1
pushhealth.com/pages/faq10 of 10
pushhealth.com/services/weight-loss1 of 1
raeliva.com/about/4 of 4
raeliva.com/faqs/11 of 11
raeliva.com/products/semaglutide-injections/1 of 1
realfood.gov/6 of 6
regs.maryland.gov/us/md/exec/comar/10.09.03.052 of 2
regs.maryland.gov/us/md/exec/comar/10.67.06.272 of 2
regulations.delaware.gov/api/file/download/html/35a18ad4-f4e7-4976-b026-bbac6686281a4 of 4
regulations.delaware.gov/api/register/submissionContent/30%20DE%20Reg%20149%2009-01-265 of 5
regulations.delaware.gov/api/register/submissionContent/30%20DE%20Reg%2015%2007-01-261 of 1
remedymeds.com/6 of 6
remedymeds.com/legal/terms-of-service7 of 7
remedymeds.com/medication/comp-sema-inj3 of 3
remedymeds.com/medication/comp-tirz-inj1 of 1
revisor.mn.gov/bills/94/2026/0/HF/4142/?body=house1 of 1
revisor.mn.gov/bills/94/2026/0/HF/4142/versions/0/1 of 1
revisor.mn.gov/statutes/cite/256B.06253 of 3
rilegislature.gov/pressrelease/_layouts/15/ril.pressrelease.inputform/DisplayForm.aspx?List=c8baae31-3c10-431c-8dcd-9dbbe21ce3e9&ID=3767211 of 1
ro.co/faq/cost-pricing-services/1 of 1
ro.co/returns-and-refunds/1 of 1
ro.co/terms-of-use/15 of 15
ro.co/weight-loss/2 of 2
ro.co/weight-loss/insurance/2 of 2
ro.co/weight-loss/pricing/18 of 18
rx.costco.com/member-value-pricing3 of 3
samsclub.com/cp/curai-health-telehealth/158001426 of 6
samsclub.com/cp/glp-1-support/138201616 of 6
saxenda.com/1 of 1
scdhhs.gov/providers/pharmacy1 of 1
sesamecare.com/blog/costco-half-price-ozempic-wegovy3 of 3
sesamecare.com/blog/sesame-weight-loss-announcement3 of 3
sesamecare.com/join/sc2024-membership-perks1 of 1
sesamecare.com/medication/semaglutide1 of 1
sesamecare.com/service/online-weight-loss-program28 of 28
sesamecare.com/terms-of-service6 of 6
skinnyrx.com/blog/skinnyrx-vs-ro-glp-1-weightloss8 of 8
southcarolina.fhsc.com/providers/documents.asp1 of 1
southcarolinablues.com/en/home/blog/categories/health-care-insurance-101/2024/pharmacy-benefits-explained.html1 of 1
southcarolinablues.com/en/home/members/prescription-drugs/medicare-advantage-and-prescription-drug-plans--pdp-.html1 of 1
southcarolinablues.com/en/home/members/prescription-drugs/other-group-plans.html2 of 2
southcarolinablues.com/en/home/providers/news-and-events/news-bulletins/commercial-glp-1-coverage-updates-for-expanded-fda-approved-indi.html8 of 8
southcarolinablues.com/en/home/providers/news-and-events/news-bulletins/important-updates-for-glp-1-provider-taxonomy-edits.html2 of 2
southcarolinablues.com/en/home/providers/news-and-events/news-bulletins/reminder--glp-1-utilization-management.html5 of 5
startwillow.com/3 of 3
startwillow.com/compound-semaglutide1 of 1
startwillow.com/compound-tirzepatide1 of 1
startwillow.com/faqs6 of 6
startwillow.com/semaglutide-tablets1 of 1
startwillow.com/tirzepatide-tablets1 of 1
static.cigna.com/assets/chcp/resourceLibrary/coveragePolicies/pharmacy_a-z.html1 of 1
struthealth.com/1 of 1
struthealth.com/faq5 of 5
struthealth.com/mens-weight-loss/injectable-tirzepatide3 of 3
struthealth.com/mens-weight-loss/oral-tirzepatide1 of 1
struthealth.com/weight-loss5 of 5
struthealth.com/weight-loss/semaglutide2 of 2
support.ivyrx.com/en/articles/10085248-general-faqs3 of 3
support.ivyrx.com/en/articles/10094882-semaglutide-weight-loss-program3 of 3
support.ivyrx.com/en/articles/10095356-ozempic1 of 1
support.plushcare.com/api/v2/help_center/en-us/articles/360021492034.json1 of 1
support.plushcare.com/api/v2/help_center/en-us/articles/360021499374.json1 of 1
support.plushcare.com/api/v2/help_center/en-us/articles/360035957554.json2 of 2
support.plushcare.com/api/v2/help_center/en-us/articles/5887584826899.json1 of 1
support.pushhealth.com/article/126-medication-prescriptions2 of 2
thecignagroup.com/about-us/milestones1 of 1
tmhp.com/news/2022-08-26-clinical-prior-authorization-xenical-no-longer-required-after-september-12-20221 of 1
tmhp.com/news/2025-11-21-wegovy-clinical-prior-authorization-new-metabolic-dysfunction-associated1 of 1
tmhp.com/news/2025-11-21-zepbound-clinical-prior-authorization-criteria-guide-updates2 of 2
trumprx.gov/p/foundayo6 of 6
trumprx.gov/p/mounjaro6 of 6
trumprx.gov/p/ozempic3 of 3
trumprx.gov/p/ozempic-pill3 of 3
trumprx.gov/p/wegovy10 of 10
trumprx.gov/p/wegovy-pill5 of 5
trumprx.gov/p/zepbound7 of 7
trumprx.gov/p/zepbound-kwikpen7 of 7
tryeden.com/policies/terms-of-service2 of 2
tryeden.com/treatment/glp-1-treatments5 of 5
tryeden.com/treatment/wegovy2 of 2
tryeden.com/treatment/zepbound1 of 1
trypeak.com/12 of 12
trypeak.com/terms-and-conditions/3 of 3
tryshed.com/7 of 7
tryshed.com/products/compounded-semaglutide-injections3 of 3
tryshed.com/products/compounded-tirzepatide-injections1 of 1
tryshed.com/products/foundayo1 of 1
tryshed.com/products/product/wegovy2 of 2
tryshed.com/products/product/zepbound-shed-membership2 of 2
tryshed.com/resources/legal/terms7 of 7
trytrimi.com/9 of 9
trytrimi.com/blog/trimi-pricing-subscription-shipping3 of 3
trytrimi.com/refund-policy2 of 2
trytrimi.com/states1 of 1
uhc.com/agents-brokers/employer-sponsored-plans/news-strategies/demand-for-glp-1-drugs1 of 1
uhc.com/member-resources/pharmacy-benefits/aca-marketplace-plans1 of 1
uhc.com/member-resources/pharmacy-benefits/faq1 of 1
uhcprovider.com/en/health-plans-by-state/rhode-island-health-plans/ri-comm-plan-home/ri-cp-pharmacy.html2 of 2
uhcprovider.com/en/prior-auth-advance-notification/prior-auth-specialty-drugs/prior-auth-pharmacy-medical-necessity.html5 of 5
uhcprovider.com/en/resource-library/news/2026/ga-commercial-plan-info.html1 of 1
uhcprovider.com/en/resource-library/news/2026/glp-1-bridge-program.html7 of 7
uhcprovider.com/en/resource-library/news/2026/ma-medicaid-weight-obesity-drug-coverage.html3 of 3
uspl.lilly.com/mounjaro/mounjaro.html1 of 1
vamedicaid.dmas.virginia.gov/bulletin/upcoming-changes-service-authorization-criteria-weight-loss-drugs4 of 4
vamedicaid.dmas.virginia.gov/bulletin/virginia-medicaid-preferred-drug-list-common-core-formulary-and-new-drug-utilization-11 of 1
walgreens.com/topic/virtual-healthcare/weight-loss.jsp18 of 18
walmart.com/cp/lillydirect/58872255 of 5
webserver.rilegislature.gov/BillText/BillText26/HouseText26/H7127Aaa.htm2 of 2
wegovy.com/2 of 2
wegovy.com/obesity/starting-wegovy/faq.html2 of 2
weightwatchers.com/us/cancellation2 of 2
weightwatchers.com/us/find-my-plan/results/?bundleId=6cb13558-78c9-4eec-ac92-0a0c98b08649&step=31 of 1
weightwatchers.com/us/termsandconditions/ww-clinic8 of 8
weightwatchers.com/us/weight-loss-medication16 of 16
weightwatchers.com/us/weight-loss-medication/foundayo2 of 2
weightwatchers.com/us/weight-loss-medication/wegovy2 of 2
weightwatchers.com/us/weight-loss-medication/wegovy-pill1 of 1
weightwatchers.com/us/weight-loss-medication/zepbound6 of 6
welcome.optumrx.com/tenncare/forms1 of 1
wellcare.com/en/california/providers/bulletins/medicare-glp-1-bridge-program2 of 2
wellcare.com/en/providers/medicare-bulletins/glp-bridge-program-20263 of 3
wellcare.com/en/resources/does-medicare-cover-weight-loss-drugs12 of 12
whitehouse.gov/fact-sheets/2025/11/fact-sheet-president-donald-j-trump-announces-major-developments-in-bringing-most-favored-nation-pricing-to-american-patients/9 of 9
whitehouse.gov/fact-sheets/2026/02/fact-sheet-president-donald-j-trump-launches-trumprx-gov-to-bring-lower-drug-prices-to-american-patients/8 of 8
whitehouse.gov/fact-sheets/2026/08/fact-sheet-president-donald-j-trump-announces-deal-with-nine-additional-pharmaceutical-manufacturers-to-lower-drug-prices-for-americans/1 of 1
whitehouse.gov/fact-sheets/2026/09/fact-sheet-president-donald-j-trump-announces-lower-drug-prices-for-all-50-state-medicaid-programs/1 of 1
whitehouse.gov/releases/2026/02/president-trump-launches-trumprx-gov-delivering-massive-immediate-savings-to-millions-of-americans/3 of 3
whitehouse.gov/releases/2026/09/president-trump-extends-most-favored-nation-pricing-to-every-medicaid-program-in-america/3 of 3
womenshealth.gov/a-z-topics/polycystic-ovary-syndrome3 of 3
wvlegislature.gov/Bill_Status/bills_history.cfm?input=743&year=2024&sessiontype=RS&btype=bill1 of 1
zepbound.lilly.com/1 of 1

All weekly reports ยท How we check prices